MedTrace Logo

Study Evaluating Growth and Tolerance of Infant Formula Containing HMOs

NCT03513744 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 340

Last updated 2023-10-16

No results posted yet for this study

Summary

The primary objective of this clinical study is to investigate the suitability of an infant formula containing five different human milk oligosaccharides to support normal physical growth (evaluated per weight gain), in comparison with infant formula without human milk oligosaccharides, when the formula is fed as the sole source of nutrition.

Conditions

  • Infant Nutrition

Interventions

DIETARY_SUPPLEMENT

human milk oligosaccharides

mixture of five different human milk oligosaccharides

Sponsors & Collaborators

  • Analyze & Realize

    collaborator NETWORK

  • Jennewein Biotechnologie GmbH

    lead INDUSTRY

Principal Investigators

  • Frank Jochum, Dr. med. · Universitaetsmedizin Berlin, Charité

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
13 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-19
Primary Completion
2021-03-03
Completion
2021-04-05

Countries

  • Germany
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03513744 on ClinicalTrials.gov